Evidence map›Paper›PMID 33846546›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021

CTNNB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component.

Abdallah Roukain, Gerasimos P Sykiotis

Open access · greenAbstract readLetter
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Circular RNAs: characteristics, functions, mechanisms, and potential applications in thyroid cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  3. Response and correction to correspondence on "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component".Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Abdallah RoukainService of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. abdallah.roukain@chuv.ch.
Gerasimos P SykiotisService of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. gerasimos.sykiotis@chuv.ch.ORCID 0000-0002-9565-4941
University Hospital of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amino Acid Sequencebeta CateninBiomarkers, TumorHigh-Throughput Nucleotide SequencingHumansImmunohistochemistryMolecular Sequence DataMutationMyofibroblastsProto-Oncogene Proteins B-rafStromal CellsThyroid Cancer, PapillaryThyroid Neoplasmsbeta CateninBiomarkers, TumorBRAF protein, humanCTNNB1 protein, humanProto-Oncogene Proteins B-raf

Identifiers

PMID33846546
OpenAlexW3152702378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.